XHKG2219
Market cap240mUSD
Jan 06, Last price
2.71HKD
1D
-2.52%
1Q
-19.35%
IPO
-83.62%
Name
Chaoju Eye Care Holdings Ltd
Chart & Performance
P/E
7.70
P/S
1.29
EPS
0.33
Div Yield, %
5.86%
Shrs. gr., 5y
0.27%
Rev. gr., 5y
16.70%
Revenues
1.37b
+38.33%
Net income
229m
+21.92%
CFO
373m
+36.27%
Dividend
Sep 11, 20240.1307 HKD/sh
Earnings
Jun 06, 2025
Profile
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, ocular fundus diseases, ocular muscle diseases, refraction errors, pediatric ophthalmology, ocular surface diseases, lacrimal diseases, orbital diseases, oculoplastic, and ocular trauma. As of December 31, 2021, it operated a network of 17 ophthalmic hospitals, 24 optical centers, and 2 clinics in Zhejiang, Jiangsu, Shanxi, and Hebei provinces, as well as in Inner Mongolia. The company was founded in 1988 and is headquartered in Beijing, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 1,369,505 38.33% | 990,044 -0.78% | ||||
Cost of revenue | 1,075,819 | 778,670 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 293,686 | 211,374 | ||||
NOPBT Margin | 21.44% | 21.35% | ||||
Operating Taxes | 78,507 | 55,942 | ||||
Tax Rate | 26.73% | 26.47% | ||||
NOPAT | 215,179 | 155,432 | ||||
Net income | 228,914 21.92% | 187,752 16.08% | ||||
Dividends | (109,750) | (62,734) | ||||
Dividend yield | 3.56% | 2.10% | ||||
Proceeds from repurchase of equity | (47,507) | (37,330) | ||||
BB yield | 1.54% | 1.25% | ||||
| Debt | ||||||
Debt current | 48,975 | 53,371 | ||||
Long-term debt | 345,466 | 326,928 | ||||
Deferred revenue | ||||||
Other long-term liabilities | 49,820 | 8,541 | ||||
Net debt | (1,158,180) | (1,382,839) | ||||
| Cash flow | ||||||
Cash from operating activities | 372,569 | 273,410 | ||||
CAPEX | (80,011) | (125,116) | ||||
Cash from investing activities | (654,095) | (464,768) | ||||
Cash from financing activities | (204,015) | (165,427) | ||||
FCF | 527,008 | 224,464 | ||||
| Balance | ||||||
Cash | 1,552,621 | 1,681,136 | ||||
Long term investments | 82,002 | |||||
Excess cash | 1,484,146 | 1,713,636 | ||||
Stockholders' equity | 467,143 | 2,317,138 | ||||
Invested Capital | 2,161,899 | 783,282 | ||||
ROIC | 14.61% | 32.91% | ||||
ROCE | 11.17% | 8.37% | ||||
| EV | ||||||
Common stock shares outstanding | 696,726 | 706,435 | ||||
Price | 4.42 4.49% | 4.23 -27.44% | ||||
Market cap | 3,079,529 3.06% | 2,988,220 -17.93% | ||||
EV | 1,939,720 | 1,631,136 | ||||
EBITDA | 417,047 | 310,740 | ||||
EV/EBITDA | 4.65 | 5.25 | ||||
Interest | 12,221 | 11,897 | ||||
Interest/NOPBT | 4.16% | 5.63% | ||||